Related Experiment Video
Updated: Jan 6, 2026
Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
Finding a link between the TRPV4 ion channel and angiogenesis: a potential therapeutic target for vascular remodeling
Gabriel Malka1, Vanessa Salucci1, Andreas Bergdahl1
1Department of Health, Kinesiology and Applied Physiology, Concordia University, Montreal, QC H3G 1M8, Canada.
Abstract:
Angiogenesis, the formation of new blood vessels, is crucial in ischemic heart disease to improve blood supply to the heart. Meanwhile, in cancer, inhibiting angiogenesis can limit tumor growth by reducing oxygen and nutrients. Calcium ions, key in cellular functions like proliferation and migration, play an important role in this process. Transient Receptor Potential Cation Channel, Vanilloid Subfamily Member 4 (TRPV4), a calcium-permeable channel, is highly expressed in endothelial cells lining blood vessels. This study explored the connection between TRPV4 and angiogenesis using an aortic ring assay. Aortic rings from 3-day-old C57Bl/6 pups were exposed to TRPV4 agonist (GSK1016790) and antagonist (HC067047) and standard growth media (control) after which maximal length and number of new sprouts were measured. The study found that the antagonist significantly reduced the number and length of new micro vessels, while the agonist increased sprout length. These findings highlight TRPV4's role in vascular remodeling, suggesting it could be a therapeutic target for treating diseases related to impaired blood flow and abnormal angiogenesis.
Insights
Transient Receptor Potential Cation Channel, Vanilloid Subfamily Member 4 (TRPV4) influences blood vessel formation. Inhibiting TRPV4 reduced new blood vessel growth, while activating it increased sprout length, suggesting therapeutic potential for vascular diseases.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Endothelial Cell Biology
Background:
- Angiogenesis is vital for ischemic heart disease and a target for cancer therapy.
- Calcium ions and TRPV4 channels are implicated in cellular processes influencing angiogenesis.
- TRPV4 is notably expressed in endothelial cells, suggesting a role in blood vessel formation.
Purpose of the Study:
- To investigate the role of Transient Receptor Potential Cation Channel, Vanilloid Subfamily Member 4 (TRPV4) in angiogenesis.
- To determine how TRPV4 modulation affects new blood vessel formation in vitro.
Main Methods:
- Utilized an aortic ring assay with explants from 3-day-old C57Bl/6 pups.
- Treated aortic rings with a TRPV4 agonist (GSK1016790) and antagonist (HC067047).
- Measured the maximal length and number of new microvessel sprouts formed.
Main Results:
- TRPV4 antagonist significantly decreased the number and length of new microvessels.
- TRPV4 agonist notably increased the length of microvessel sprouts.
- TRPV4 activity directly correlates with the extent of angiogenesis in the assay.
Conclusions:
- TRPV4 plays a significant role in regulating angiogenesis and vascular remodeling.
- TRPV4 represents a potential therapeutic target for conditions involving abnormal angiogenesis or impaired blood flow.
- Further research into TRPV4 modulation could yield treatments for cardiovascular diseases and cancer.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
01:10Mechanism of Angiogenesis
01:27Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: